REQUEST A DEMO
Total
USD $0.00
Search more companies

Siribuncha Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Siribuncha Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Siribuncha Company Limited is an enterprise in Thailand, with the main office in Bangkok , Special Governed District of. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on May 15, 2026. There are currently 100 (2024) people employed by Siribuncha Company Limited. In 2024, the company reported a net sales revenue increase of 8.42%. A growth of 2.15% was recorded in its total assets. The net profit margin of Siribuncha Company Limited increased by 2.66% in 2024.

Headquarters
37 Soi Wachiratham Sathit 51
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10260

Contact Details: Purchase the Siribuncha Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Siribuncha Company Limited report to view the information.
Financial Auditors:
Purchase the Siribuncha Company Limited report to view the information.
Incorporation Date:
May 15, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Siribuncha Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
8.42%
Total Operating Revenue
8.25%
Operating Profit
128.61%
EBITDA
128.61%
Net Profit/Loss for the Period
281.62%
Total Assets
2.15%
Total Equity
-25.35%
Operating Profit Margin
2.88%
Net Profit Margin
2.66%
Return on Equity (ROE)
14.48%
Debt / Equity
30.22%
Quick Ratio
-0.15%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?